Evelyn Partners Investment Management (Europe) Ltd

Position in JNJ — Johnson & Johnson

CIK 2065055 Dublin, L2

Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,377,187

+$624,770 QoQ

Shares Held

17,907

-1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Evelyn Partners Investment Management (Europe) Ltd holds $9,080,450 across 5 Drug Manufacturers - General names. JNJ ranks #1 (48.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	17,907	$4,377,187
2	AZN	Astrazeneca PLC	21,991	$4,337,065
3	ABBV	AbbVie Inc.	1,635	$355,596
4	MRK	Merck & Co., Inc.	87	$10,465
5	OGN	Organon & Co.	23	$137

All Filings in JNJ

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,377,187	17,907	-1.2%	Shares	Sole	2026-05-15
2025-12-31	$3,752,417	18,132	-3.3%	Shares	Sole	2026-02-13
2025-09-30	$3,476,068	18,747	-0.8%	Shares	Sole	2025-11-14
2025-06-30	$2,886,211	18,895	-6.6%	Shares	Sole	2025-11-26
2025-03-31	$3,354,445	20,227	-12.9%	Shares	Sole	2025-12-08
2024-12-31	$3,357,497	23,216	—	Shares	Sole	2025-12-11
No filing history on record for this holder in this stock.